96 related articles for article (PubMed ID: 19039946)
1. Study of the correlation between clinical efficiency of impaza and serum ADMA level.
Zhavbert ES; Tarasov SA; Dugina JL; Sergeeva SA; Gamidov SI; Mazo EB; Epstein OI
Bull Exp Biol Med; 2008 Mar; 145(3):367-70. PubMed ID: 19039946
[TBL] [Abstract][Full Text] [Related]
2. Impaza and sildenafil: comparison of clinical effectiveness in patients with erectile dysfunction.
Petrov VI; Vekel'yan AS; Martyushev AV; Sergeeva SA; Smolenov IV; Epstein OI
Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():150-1. PubMed ID: 12949684
[TBL] [Abstract][Full Text] [Related]
3. Use of impaza in the treatment of erectile dysfunction in patients with essential hypertension and CHD.
Neimark AI; Aliev RT; Muzalevskaya NI; Krainichenko SV; Vorob'eva EN; Tarasova TS
Bull Exp Biol Med; 2009 Aug; 148(2):328-31. PubMed ID: 20027361
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the efficiency and safety of combined treatment with impaza and nitrates in CHD patients with erectile dysfunction.
Zhavbert ES; Kachanova MV; Tarasov SA; Dugina YL; Sergeeva SA; Dovgalevskii PY; Epshtein OI
Bull Exp Biol Med; 2009 Aug; 148(2):325-7. PubMed ID: 20027360
[TBL] [Abstract][Full Text] [Related]
5. Experimental study of the efficiency of impaza on the model of chronic aseptic prostatic inflammation.
Borovskaya TG; Fomina TI; Pakhomova AV; Ermolaeva LA; Poluektova ME; Zhavbert ES; Dugina JL; Kheifets IA; Epstein OI
Bull Exp Biol Med; 2012 Dec; 154(2):217-9. PubMed ID: 23330129
[TBL] [Abstract][Full Text] [Related]
6. Effect of impaza on cardiovascular system.
Markel' AL; Zhavbert ES; Tarasov SA; Dugina YL; Kachanova MV; Sergeeva SA; Epshtein OI
Bull Exp Biol Med; 2009 Sep; 148(3):518-9. PubMed ID: 20396728
[TBL] [Abstract][Full Text] [Related]
7. Anxiolytic and antidepressant characteristics of impaza.
Voronina TA; Molodavkin GM; Zhavbert ES; Tarasov SA; Kheyfets IA; Dugina JL; Sergeeva SA; Epstein OI
Bull Exp Biol Med; 2008 Jun; 145(6):735-7. PubMed ID: 19110564
[TBL] [Abstract][Full Text] [Related]
8. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L-arginine in patients with arteriogenic and non-arteriogenic erectile dysfunction.
Paroni R; Barassi A; Ciociola F; Dozio E; Finati E; Fermo I; Ghilardi F; Colpi GM; Corsi MM; Melzi d'Eril GV
Int J Androl; 2012 Oct; 35(5):660-7. PubMed ID: 22519580
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.
Böger RH; Bode-Böger SM; Szuba A; Tsao PS; Chan JR; Tangphao O; Blaschke TF; Cooke JP
Circulation; 1998 Nov; 98(18):1842-7. PubMed ID: 9799202
[TBL] [Abstract][Full Text] [Related]
10. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.
Pasini AF; Garbin U; Stranieri C; Boccioletti V; Mozzini C; Manfro S; Pasini A; Cominacini M; Cominacini L
Am J Hypertens; 2008 Nov; 21(11):1251-7. PubMed ID: 18772860
[TBL] [Abstract][Full Text] [Related]
11. Efficiency of combined therapy with impaza and type 5 phosphodiesterase inhibitors in prophylactics of posttraumatic erectile dysfunction.
Ibishev KhS
Bull Exp Biol Med; 2009 Aug; 148(2):322-4. PubMed ID: 20027359
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of erectile dysfunction in patients with metabolic syndrome].
Gamidov SI; Sotnikova EM; Gasanov RV
Urologiia; 2007; (5):44-8. PubMed ID: 18254225
[TBL] [Abstract][Full Text] [Related]
13. Asymmetric dimethyl arginine levels correlate with cardiovascular risk factors in patients with erectile dysfunction.
Wierzbicki AS; Solomon H; Lumb PJ; Lyttle K; Lambert-Hammill M; Jackson G
Atherosclerosis; 2006 Apr; 185(2):421-5. PubMed ID: 16046217
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo effects of probucol on hydrolysis of asymmetric dimethyl L-arginine and vasospasm in primates.
Pluta RM; Jung CS; Harvey-White J; Whitehead A; Shilad S; Espey MG; Oldfield EH
J Neurosurg; 2005 Oct; 103(4):731-8. PubMed ID: 16266057
[TBL] [Abstract][Full Text] [Related]
15. The use of drugs Impaza and Nebido in the treatment of erectile dysfunction in patients with type 2 diabetes mellitus of reproductive age.
Mehtiyev T
Georgian Med News; 2013 Jun; (219):61-5. PubMed ID: 23863213
[TBL] [Abstract][Full Text] [Related]
16. [Potentials for the correction of endothelial and erectile dysfunction in patients after coronary artery bypass grafting].
Pomeshkin EV; Neĭmark AI; Pomeshkina SA; Barabash OL
Urologiia; 2013; (5):43-6, 48-9. PubMed ID: 24437240
[TBL] [Abstract][Full Text] [Related]
17. Serum asymmetric dimethylarginine and nitric oxide levels in Turkish patients with acute ischemic stroke.
Ercan M; Mungan S; Güzel I; Celik HT; Bal C; Abusoglu S; Akbulut D; Oguz EF; Yilmaz FM
Adv Clin Exp Med; 2019 May; 28(5):693-698. PubMed ID: 30170483
[TBL] [Abstract][Full Text] [Related]
18. Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis.
Antoniades C; Shirodaria C; Leeson P; Antonopoulos A; Warrick N; Van-Assche T; Cunnington C; Tousoulis D; Pillai R; Ratnatunga C; Stefanadis C; Channon KM
Eur Heart J; 2009 May; 30(9):1142-50. PubMed ID: 19297385
[TBL] [Abstract][Full Text] [Related]
19. ADMA and NOS regulation in chronic renal disease: beyond the old rivalry for l-arginine.
Dobrian AD
Kidney Int; 2012 Apr; 81(8):722-4. PubMed ID: 22460653
[TBL] [Abstract][Full Text] [Related]
20. Relationship between asymmetric dimethylarginine, nitrite and genetic polymorphisms: Impact on erectile dysfunction therapy.
Azevedo AMM; Brites-Anselmi G; Pinheiro LC; de Almeida Belo V; Coeli-Lacchini FB; Molina CAF; de Andrade MF; Tucci S; Hirsch E; Tanus-Santos JE; Lacchini R
Nitric Oxide; 2017 Dec; 71():44-51. PubMed ID: 29074293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
